EP300 Degradation and AKT Inhibition Slow Osteosarcoma in Preclinical Models
A PROTAC that degrades EP300 combined with AKT inhibition slowed tumor growth and extended survival in patient-derived osteosarcoma mouse models, ...
A PROTAC that degrades EP300 combined with AKT inhibition slowed tumor growth and extended survival in patient-derived osteosarcoma mouse models, ...
A new in vitro study finds that the lichen-derived compound usnic acid dramatically enhances posaconazole against drug-resistant fungi through ROS ...
A new cell study shows that C-phycocyanin can strip away Mcl-1-driven resistance and make the BH3-mimetic ABT-737 far more lethal ...
Researchers developed HALO, a machine-learning framework that predicts antibacterial drug synergy from multi-level bioactivity features while exposing how data leakage ...
A new benchmark reveals that drug synergy prediction models often rely on memorizing historical data rather than learning generalizable pharmacological ...
Researchers have built ProteinTalks, an AI virtual cell model trained on more than 38 million time-resolved protein measurements from perturbed ...
New research shows the proteasome inhibitor bortezomib kills cutaneous T-cell lymphoma cells through ROS-dependent mitochondrial apoptosis while suppressing the SKP2-p21/p27 ...
Japanese researchers found that the metabolic enzyme ME1 predicts poor outcomes in endometrioid endometrial carcinoma and that inhibiting it restores ...
Researchers report that combining host-directed and direct-acting antivirals yields synergistic inhibition across alpha, beta, and gamma herpesviruses in cell culture ...
Dutch researchers have shown that combining the bladder chemotherapy drug mitomycin C with ATR kinase inhibitors eradicates patient-derived non-muscle invasive ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine